Caffeoyl-Prolyl-Histidine Amide Inhibits Fyn and Alleviates Atopic Dermatitis-Like Phenotypes via Suppression of NF-kappa B Activation
- Authors
- Jeong, Hayan; Shin, Jee Youn; Lee, Kwanghyun; Lee, Su-Jin; Chong, Hyo-Jin; Jeong, Hyeri; Jeon, Young-Eun; Shin, Dong-Sik; Jang, Sunhyae; Kim, Kyu Han; Kim, Seok-In; Lee, Yoon-Sik; Ju, Bong-Gun
- Issue Date
- Oct-2020
- Publisher
- MDPI
- Citation
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.21, no.19, pp 1 - 20
- Pages
- 20
- Journal Title
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Volume
- 21
- Number
- 19
- Start Page
- 1
- End Page
- 20
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/1152
- DOI
- 10.3390/ijms21197160
- ISSN
- 1661-6596
1422-0067
- Abstract
- Caffeic acid (CA) is produced from a variety of plants and has diverse biological functions, including anti-inflammation activity. It has been recently demonstrated that caffeoyl-prolyl-histidine amide (CA-PH), which is CA conjugated with proline-histidine dipeptide, relieves atopic dermatitis (AD)-like phenotypes in mouse. In this study, we investigated the molecular mechanism underlying CA-PH-mediated alleviation of AD-like phenotypes using cell line and AD mouse models. We confirmed that CA-PH suppresses AD-like phenotypes, such as increased epidermal thickening, infiltration of mast cells, and dysregulated gene expression of cytokines. CA-PH suppressed up-regulation of cytokine expression through inhibition of nuclear translocation of NF-kappa B. Using a CA-PH affinity pull-down assay, we found that CA-PH binds to Fyn. In silico molecular docking and enzyme kinetic studies revealed that CA-PH binds to the ATP binding site and inhibits Fyn competitively with ATP. CA-PH further suppressed spleen tyrosine kinase (SYK)/inhibitor of nuclear factor kappa B kinase (IKK)/inhibitor of nuclear factor kappa B (I kappa B) signaling, which is required for nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) activation. In addition, chronic application of CA-PH, in contrast with that of glucocorticoids, did not induce up-regulation of regulated in development and DNA damage response 1 (REDD1), reduction of mammalian target of rapamycin (mTOR) signaling, or skin atrophy. Thus, our study suggests that CA-PH treatment may help to reduce skin inflammation via down-regulation of NF-kappa B activation, and Fyn may be a new therapeutic target of inflammatory skin diseases, such as AD.
- Files in This Item
-
Go to Link
- Appears in
Collections - 공과대학 > 화공생명공학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.